Current symptomatology in multiple sclerosis and neuromyelitis optica

European Journal of Neurology

Volumn 22, Issue 2, 2015, Pages 299-304

  Muto, M ^a   Mori, M ^a   Sato, Y ^b   Uzawa, A ^a   Masuda, S ^a   Uchida, T ^a   Kuwabara, S ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Multiple sclerosis; Neuromyelitis optica; Paroxysmal symptoms; Symptomatology

Indexed keywords

ADULT; ARTICLE; ATAXIA; BURNING SENSATION; COMPARATIVE STUDY; DYSARTHRIA; FATIGUE; FEMALE; GIRDLE SENSATION; HUMAN; JAPANESE (PEOPLE); LHERMITTE SIGN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PRURITUS; SPINAL CORD LESION; SYMPTOMATOLOGY; TONIC SEIZURE; UHTHOFF PHENOMENON; JAPAN; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; PATHOPHYSIOLOGY;

ADULT; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA;

EID: 84920582445     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12566     Document Type: Article

References (37)

1. Bruck W, Schmied M, Suchanek G, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994; 35: 65-73.
2. Matthews WB, Acheson ED, Batchelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. Churchill Livingstone: New York, 1985.
3. Miley CE, Forster FM. Paroxysmal signs and symptoms in multiple sclerosis. Neurology 1974; 24: 458-461.
4. Shibasaki H, Kuroda Y, Kuroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J Neurol Sci 1974; 23: 215-222.
5. Solaro C, Brichetto G, Amato MP, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004; 63: 919-921.
6. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1, 084 cases. Neurology 1975; 25: 845-851.
7. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
8. Nakashima I, Fukazawa T, Ota K, et al. Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol 2007; 254: 488-492.
9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
10. Kanamori Y, Nakashima I, Takai Y, et al. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology 2011; 77: 652-658.
11. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010; 68: 757-761.
12. Iorio R, Lucchinetti CF, Lennon VA, et al. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology 2011; 77: 1644-1646.
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58: 840-846.
14. Mandler RN. Neuromyelitis optica - Devic's syndrome, update. Autoimmun Rev 2006; 5: 537-543.
15. Ostermann PO, Westerberg CE. Paroxysmal attacks in multiple sclerosis. Brain 1975; 98: 189-202.
16. Twomey JA, Espir ML. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43: 296-304.
17. Kanchandani R, Howe JG. Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. J Neurol Neurosurg Psychiatry 1982; 45: 308-312.
18. Al-Araji AH, Oger J. Reappraisal of Lhermitte's sign in multiple sclerosis. Mult Scler 2005; 11: 398-402.
19. Vercoulen JH, Hommes OR, Swanink CM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996; 53: 642-649.
20. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981; 49: 253-271.
21. Selhorst JB, Saul RF. Uhthoff and his symptom. J Neuroophthalmol 1995; 15: 63-69.
22. Ochiai H, Yamakawa Y, Minato S, Nakahara K, Nakano S, Wakisaka S. Clinical features of the localized girdle sensation of mid-trunk (false localizing sign) appeared in cervical compressive myelopathy patients. J Neurol 2002; 249: 549-553.
23. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008; 196: 181-187.
24. Prineas JW, Connell F. The fine structure of chronically active multiple sclerosis plaques. Neurology 1978; 28: 68-75.
25. Sozzi G, Marotta P, Piatti L, Taborelli A, Dorizzi A. Paroxysmal sensory-motor attacks due to a spinal cord lesion identified by MRI. J Neurol Neurosurg Psychiatry 1987; 50: 490-492.
26. Spissu A, Cannas A, Ferrigno P, Pelaghi AE, Spissu M. Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov Disord 1999; 14: 331-335.
27. Kira J. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci 2011; 311: 69-77.
28. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
29. Uzawa A, Mori M, Masuda S, Muto M, Kuwabara S. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2013; 84: 517-522.
30. Kira J. Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis. Pathophysiology 2011; 18: 69-79.
31. Fukazawa T, Tashiro K, Hamada T, et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern Med 1992; 31: 349-352.
32. Schmidt FR, Costa FH, Silva FM, et al. Paroxysmal dystonia and neuromyelitis optica. Arq Neuropsiquiatr 2012; 70: 271-272.
33. Kim SM, Go MJ, Sung JJ, Park KS, Lee KW. Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. Arch Neurol 2012; 69: 1026-1031.
34. Usmani N, Bedi G, Lam BL, Sheremata WA. Association between paroxysmal tonic spasms and neuromyelitis optica. Arch Neurol 2012; 69: 121-124.
35. Uzawa A, Mori M, Sawai S, et al. Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clin Chim Acta 2013; 421: 181-183.
36. Araki M, Aranami T, Matsuoka T, Nakamura M, Miyake S, Yamamura T. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol 2013; 23: 827-831.
37. Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990; 100: 217-222.